 |
Adjuvant
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Adjuvant
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Adverse effects.
The Skin Immune System and Intradermal Delivery of Vaccines: A Review [Volume 7, Number 2] |
|
Agonist
Roles and Functions of Toll-Like Receptors in Coronavirus Infections: Forthcoming Vaccine and Therapeutic Strategies for Confronting COVID-19 [Volume 8, Number 2] |
|
Anti-NA drug resistance.
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Antibody response
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium [Volume 6, Number 2] |
|
Antigen presentation.
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
BCG Vaccine
Back to the Basics: The Good Old BCG for COVID-19? [Volume 8, Number 1] |
|
Bacillus subtilis.
Construction of chimeric protein 3M2e.FliC and its immunoinformatics analyses and expression in Bacillus subtilis [Volume 3, Number 3] |
|
Baculovirus.
Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism [Volume 2, Number 3] |
|
Biotechnology.
Challenge-based approaches for policy-making in vaccine development and production [Volume 5, Number 1] |
|
C57BL/6 mice
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
COVID-19
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
COVID-19
The Potential of Self-amplifying RNA Vaccines for Infectious Diseases and COVID-19 [Volume 7, Number 1] |
|
COVID-19
Parent’s Knowledge on Rotavirus Diarrhea and Vaccine in Indonesia [Volume 7, Number 1] |
|
COVID-19 Vaccine
The Well-Recognized Ability of Melatonin to Potentiate an Equilibrated Immune Response Calls for an Urgent Study about Its Use as an Adjuvant in Anti-SARS-CoV-2 Vaccines [Volume 7, Number 2] |
|
COVID-19 vaccines
Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges [Volume 6, Number 2] |
|
Caco-2 cell line
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Carbamazepine-induced hypersensitivity reactions
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
ChAd0x1 nCoV-19 Vaccine
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Chitosan
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
Combination therapy
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Conjugate
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Conjugate.
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Corneal graft rejection
Commentary on Corneal Graft Rejection after COVID-19 Vaccination: Our Experience and Concerns [Volume 8, Number 2] |
|
Covaxin
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Cross-sectional study
Basic characteristics of patients with COVID-19 after SARS‐CoV‐2 vaccine: One cross-sectional study in Iran [Volume 9, Number 1] |
|
DNA Vaccine
The Effects of Heat Shock Proteins on the Expression of HIV-1 Nef Antigen in Mammalian Cells [Volume 7, Number 1] |
|
DNA-based vaccine.
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Direct Agglutination Test (DAT).
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Docking
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
EGFP
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
ELFA
Establishment a Carcinoembryonic Antigen Stable Cell Line for Cancer Immunotherapy Study [Volume 9, Number 1] |
|
Electroporation
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers [Volume 1, Number 1] |
|
Epitopes
In Silico Evaluation of a Mutant Toxic Shock Syndrome Toxin-1 (TSST-1) of Staphylococcus aureus as a Putative Vaccine Candidate [Volume 7, Number 2] |
|
Expression
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Expression.
Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis [Volume 5, Number 1] |
|
Expression.
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Glycoprotein
In silico study to predict and characterize of SARS CoV 2 Surface glycoprotein [Volume 7, Number 1] |
|
HEiAP
Policy Coherence for Vaccine Production to Reduce Health Inequalities [Volume 9, Number 2] |
|
HPV pseudovirus.
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
HSV-tk/GCV
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
Hepatitis A virus
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Hepatitis B
Pasteur Institute of Iran; a Leading Institute in the Production and Development of Vaccines in Iran [Volume 6, Number 1] |
|
Humoral immune responses.
Different protein expression systems can influence the direction of the immune responses against HCV core protein in animal model [Volume 2, Number 3] |
|
IL-6 blockage
An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm [Volume 8, Number 2] |
|
Immune response
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Immune responses
Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus [Volume 7, Number 2] |
|
Immunization
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
Immunogenic epitopes
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
In silico analysis
In silico Design of Truncated Omp31 Protein of Brucella melitensis: Its Cloning and High Level Expression in Escherichia coli [Volume 1, Number 1] |
|
In-silico
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development [Volume 10, Number 1] |
|
Inactivation.
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Iran
In-silico Analysis of Pneumococcal Heat-Shock Protein (DnaJ) to Predict Novel Multi-Epitope Vaccine Candidates [Volume 9, Number 1] |
|
Iran
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Iran.
The Shift of HAV Infection in to adulthood in Iran: Consideration for HAV Vaccination [Volume 3, Number 1] |
|
LD50.
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Lentiviral vectors.
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
MDCK-SIAT1 cells
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Macrophage
Effects of Microgravity on the Monocyte/Macrophage Physiology and the Potential Implication in Immune Responses to Vaccines [Volume 6, Number 2] |
|
Meningitis
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Mucosal vaccines.
Lactococcus lactis as a live delivery vector [Volume 3, Number 3] |
|
Multi-epitope vaccine
In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella [Volume 10, Number 1] |
|
Mycobacteria antigen.
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Mycobacterium tuberculosis
Evaluation of Human Serological Response to Recombinant TB10.4 Antigen of Mycobacterium tuberculosis [Volume 1, Number 2] |
|
Mycobacterium tuberculosis.
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
NMR.
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
NSP-free FMD vaccine.
Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen [Volume 3, Number 3] |
|
Neutralizing Antibodies
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Nigeria
An Assessment of the 2017-2018 Post Measles Campaign Coverage Survey in the South-south Zone of Nigeria [Volume 7, Number 2] |
|
Pasteur Institute of Iran
Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017 [Volume 8, Number 1] |
|
Pichia pastoris
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Policy coherence.
Vaccine production industry in Iran and the necessity for policy coherence [Volume 4, Number 3] |
|
Poly-Epitope Vaccine
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
Post-exposure prophylaxis
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Probiotic.
Immunization of Litopenaeus vannamei shrimp against white spot syndrome virus (WSSV) by gamma-irradiated WSSV plus Vibrio paraheomolyticus [Volume 3, Number 1] |
|
Prophylactic vaccine.
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
Protein Vaccine.
Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate [Volume 4, Number 1] |
|
Protein solubilization
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Protein-based vaccine.
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Quality
Mitigation of Scale-Up Risks in Technology Transfer of Vaccines and other Bioproducts [Volume 10, Number 2] |
|
RSM method
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Recipient.
Free vaccinations and clinical history takings of the vaccine recipients: reliable or not? [Volume 5, Number 1] |
|
Recombinant protein.
Production of Polyomavirus and Herpesvirus Recombinant Glycoproteins with Immunoreactivity Using a Rapid and Novel Expression System in Insect Cells for Applications in Vaccines and Serological Assays [Volume 8, Number 1] |
|
Regulation.
Overview of the validation procedures for a vaccine production: from R&D level to the pre-qualification stage [Volume 2, Number 1] |
|
Reverse genetics
Rabies vaccine: progress and prospective [Volume 10, Number 1] |
|
SIV
Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism [Volume 6, Number 2] |
|
SPACE model.
Strategies of Hepatitis B vaccine export to the Middle East and Central Asian countries [Volume 2, Number 3] |
|
Shigella
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Sinopharm BBIBP-CorV
Lessons Learned from Global Administration of Sinopharm (BBIBP-CorV) Vaccine and Its Efficacy against COVID-19 in Older People [Volume 8, Number 2] |
|
Specificity
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens [Volume 10, Number 1] |
|
Staphylococcus epidermidis
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci [Volume 6, Number 2] |
|
Subunit vaccine.
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
TLR-5
Sequence Diversity of FliC Protein from Enterobacteriaceae Family to Introducing a Promising Epitope-Delivery Platform [Volume 7, Number 2] |
|
TRIPS
Which One Should Be Prioritized During Pandemics: Patents or Global Health? [Volume 10, Number 1] |
|
Th2 immune responses
The Importance of Group 2 Innate Lymphoid Cells to Improve the Protective Immunity in Parasitic Helminth Infections [Volume 7, Number 1] |
|
Thrombocytopenia
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Tumor challenging model.
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
V. cholerae.
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Vaccination
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Vaccination
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
Vaccination.
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Vaccine
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Vaccine
Phylogenetic Analysis, Cloning and Expression of Delta Amastin Encoding Gene from Leishmania major as a Vaccine Candidate [Volume 9, Number 1] |
|
Vaccine
Characterization and Inactivation of Infectious Bursal Disease Virus for Use as a Vaccine and Immunodiagnostic Reagent [Volume 7, Number 2] |
|
Vaccine
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Vaccine Preventable Diseases
The Healthcare Workers’ Vaccination – current Policy and Recommendations [Volume 9, Number 1] |
|
Vaccine hesitancy
In silico design of multiepitope vaccine candidate against SARS CoV and CoV2 [Volume 7, Number 2] |
|
Vaccine hesitancy
Ethical Considerations and Challenges Duringthe COVID-19 Vaccine Deployment: Experiences from an Indian Perspective [Volume 7, Number 2] |
|
Vaccine vehicle
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform [Volume 9, Number 2] |
|
Vaccine.
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Vaccine.
The role of vaccination in controlling the outbreak of infectious diseases: a mathematical approach [Volume 5, Number 1] |
|
Vaccine.
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Vaccine.
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Vaccines
Risk Factors for Persistent Human Papillomavirus (HPV) Infection after Conization: A Retrospective Case-Control Study Showed No Significant Association with HPV Vaccination [Volume 7, Number 2] |
|
Viral immunity
Feeding Eggs from Hens Immunized with Specific KLH-Conjugated HIV Peptide Candidate Vaccines to Chicks Induces Specific Anti-HIV gp120 and gp41 Antibodies that Neutralize the Original HIV Antigens [Volume 7, Number 2] |
|
Virus Engineering
Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene [Volume 8, Number 1] |
|
Yellow Fever
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
accuracy
Enhancing the Accuracy of Semi-quantitative Endotoxin Evaluation in Biopharmaceuticals and Vaccines R&D [Volume 9, Number 2] |
|
acute myeloid leukemia (AML)
Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML) [Volume 1, Number 2] |
|
adjuvant
Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken [Volume 6, Number 2] |
|
adjuvant.
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections [Volume 4, Number 1] |
|
adjuvanticity
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
armed forces
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel [Volume 1, Number 2] |
|
cross-protective activity
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
delivery systems.
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
dropout
Determinants of Immunization Status Among Children Between 13-24 Months of Age in Maharashtra, India – A Community Based Cross-Sectional Study [Volume 7, Number 2] |
|
drug eruptions
Cutaneous Reactions after COVID-19 vaccines [Volume 8, Number 1] |
|
ebola disease
Analysis and Control of an SEIQR Epidemic Model with Application to Ebola Disease Vaccination [Volume 8, Number 1] |
|
epitope prediction
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
erythropoietin.
Purification of human anti-erythropoietin polyclonal antibodies by precipitation and chromatography as an optimized method with potential application in vaccine studies [Volume 3, Number 3] |
|
expiration date.
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
fusion protein.
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
healthcare workers.
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
high energy and protein diets
Application of High Energy and Protein Diets in Combination with a Live Avirulent Escherichia coli F4 Vaccine Against Post-Weaning Diarrhea [Volume 7, Number 1] |
|
immune response.
Enhancement of cell-mediated immune response in chickens by combination of TIR-TLR7 with inactivated Newcastle disease vaccine [Volume 5, Number 1] |
|
immune responses
The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines [Volume 8, Number 2] |
|
immunogenicity
A Global Overview of Tuberculosis Vaccine Development [Volume 9, Number 2] |
|
immunogenicity
Comparative Sequence Analysis, Pathogenicity and Immunogenicity of Attenuated Fowl Adenovirus Isolates as Experimental Vaccines against Inclusion Body Hepatitis of Commercial Broiler Chickens [Volume 8, Number 1] |
|
immunogenicity simulation
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
kinetic model
Endotoxin Removal from Biopharmaceuticals and Vaccines by an Antimicrobial Peptide-Based Affinity Matrix: a Kinetics Study [Volume 10, Number 2] |
|
leishmaniasis.
Sand fly saliva: toward a vaccine against leishmaniases [Volume 2, Number 3] |
|
lymphocyte proliferation assay.
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
pET-28a.
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
passive immunization
Evaluation of the effectiveness of infectious diseases immunoprophylaxis (review of our own research on the model of tick-borne encephalitis) [Volume 8, Number 1] |
|
pertussis
Impact of vaccination on epidemiology of diphtheria and pertussis [Volume 2, Number 1] |
|
pollen grain
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
polyethylene glycol.
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
prevention.
BCG vaccine and pulmonary tuberculosis [Volume 4, Number 1] |
|
pseudovirion.
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
quantitative
Quantitative Approaches for Causality Assessment of Adverse Events Following Immunisation for COVID-19 Vaccines [Volume 8, Number 1] |
|
radiologic outcome
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
seroepidemiology
Seroepidemiology of Pertussis in a Set of Under One Year Old Iranian Children [Volume 6, Number 1] |
|
serum resistance factors.
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
suspension culture.
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
transgenic plants
Recombinant vaccines against Newcastle Disease: current trends and research agenda [Volume 8, Number 1] |
|
typing.
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
vaccine
The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy [Volume 6, Number 1] |
|
vaccine
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis [Volume 5, Number 2] |
|
vaccine vehicle
Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa [Volume 6, Number 1] |
|
vaccine vehicle.
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
vaccine vehicle.
Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles [Volume 4, Number 3] |
|
vaccine.
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
vaccine.
Allelic variations between vaccine strains and circulating strains in pxtP of Bordetella pertussis in Iran [Volume 2, Number 1] |
|
virus-like particles.
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
